This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Inspur Suzhou Intelligent Technology Co., Ltd, Nanjing Sanhome Pharmaceutical Co., Ltd.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations and Contributions of Inventor Liang Jin
Introduction
Liang Jin is a notable inventor based in Jiangsu, China. He has made significant contributions to the fields of technology and pharmaceuticals, holding a total of 2 patents. His work focuses on advanced methods and systems that have the potential to impact various industries.
Latest Patents
Liang Jin's latest patents include a person re-identification method, system, and device, as well as an anti-CD47 antibody and its applications. The person re-identification method involves acquiring a sample set for training, utilizing data re-sampling and cross-validation methods to develop a trained model. This model is then used for person re-identification, ensuring that individuals in different groups are classified correctly. The anti-CD47 antibody patent relates to a pharmaceutical composition that exhibits significant antitumor activity and high affinity with human CD47 protein, making it a promising candidate for anti-tumor drug development.
Career Highlights
Throughout his career, Liang Jin has worked with reputable companies such as Inspur Suzhou Intelligent Technology Co., Ltd. and Nanjing Sanhome Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects.
Collaborations
Liang Jin has collaborated with notable coworkers, including Runze Zhang and Zhenhua Guo. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Liang Jin's contributions to technology and pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in these fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile